UK Fibromyalgia Sufferers Petition the National Health Service to Integrate and Pay for BioElectronics' ActiPatch® Therapy

FREDERICK, Md., Nov. 26, 2014 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer and healthcare medical devices announced today that Pifflers United Chronic and Invisible Illnesses Support Community, www.facebook.com/PifflersUnited, is petitioning the United Kingdom's NHS' National Institute for Health & Care Excellence (NICE) for new guidelines for effective Fibromyalgia pain management.

Fibromyalgia (FM) is a chronic condition of widespread pain and profound fatigue. The pain tends to be felt as diffuse aching or burning, often described as head to toe.  Fibromyalgia patients receive ad hoc treatment and NICE Guidelines for the treatment of Fibromyalgia are needed to ensure sufferers are treated appropriately and consistently.

The group members used ActiPatch Therapy and were surveyed.  Upon completion, the survey showed an average pain reduction of 33% with 79% of them reporting a pain decrease.  When analyzed excluding those with no or very little pain improvement, the therapeutic rate was 69% with a 47% reduction in pain.

The Pifflers United petition calls on the UK Government to roll out a cohesive plan for the treatment and management of Fibromyalgia, including the following:

1. Produce NICE Guidelines for the treatment of Fibromyalgia
2. Arrange for Clinical Trials of the ActiPatch device, following on from the 7-day trial results conducted by Fibromyalgia sufferers in the online support community.
3. Following on from successful clinical trials of ActiPatch, to arrange for the ActiPatch device to be available on prepay prescription for the treatment and management of Fibromyalgia pain. 

To view the e-petition and study results, please visit www.facebook.com/PifflersUnited.

About BioElectronics Corporation
BioElectronics Corporation is a leader in biophysics and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy; and HealFast® Therapy for dogs, cats and horses.  For more information, please visit www.bielcorp.com.

BioElectronics Contact:
Paul Knopick
940.262.3584
[email protected]  

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/uk-fibromyalgia-sufferers-petition-the-national-health-service-to-integrate-and-pay-for-bioelectronics-actipatch-therapy-300001386.html

SOURCE BioElectronics Corporation

Related Links

http://www.bioelectronicscorp.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED